KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Other Accumulated Expenses (2016 - 2025)

Charles River Laboratories International has reported Other Accumulated Expenses over the past 17 years, most recently at $222.2 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 14.51% year-over-year to $222.2 million; the TTM value through Dec 2025 reached $222.2 million, up 14.51%, while the annual FY2025 figure was $222.2 million, 14.51% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $222.2 million at Charles River Laboratories International, up from $216.0 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $222.2 million in Q4 2025 and troughed at $97.3 million in Q1 2021.
  • A 5-year average of $184.3 million and a median of $196.2 million in 2024 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: decreased 10.63% in 2021 and later soared 48.47% in 2022.
  • Year by year, Other Accumulated Expenses stood at $140.4 million in 2021, then soared by 45.67% to $204.6 million in 2022, then decreased by 0.67% to $203.2 million in 2023, then decreased by 4.53% to $194.0 million in 2024, then grew by 14.51% to $222.2 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for CRL at $222.2 million in Q4 2025, $216.0 million in Q3 2025, and $207.2 million in Q2 2025.